Palbociclib
| CAS No. | 571190-30-2 |
|---|---|
| MDL No. | MFCD11840850 |
| MF | C24H29N7O2 |
| MW | 447.50 |
| InChI Key | AHJRHEGDXFFMBM-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Palbociclib is a pyridopyrimidine compound with the structure 2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7-one, bearing methyl, acetyl, and cyclopentyl substituents at positions 5, 6, and 8, respectively. It is used in combination with letrozole to treat metastatic breast cancer. It functions as a cyclin-dependent kinase inhibitor (EC 2.7.11.22) and an antineoplastic agent. It is also classified as an aminopyridine, secondary amino compound, piperidine, aromatic ketone, cyclopentane, and tertiary amino compound.
| CAS No. | 571190-30-2 |
|---|---|
| Product Name | Palbociclib |
Biological Targets
CCND1·CDK6·CDK4
Associated Conditions
urothelial carcinoma·non-small cell lung carcinoma·sarcoma·colon carcinoma·breast ductal adenocarcinoma·
* The information provided here is compiled from public sources and is for reference only.
